Concurrent Temozolomide and Dose-Escalated Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma

Lignende værker

• Association of (11)C-Methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme
  af: Lee, Irwin H., et al.
  Udgivet: (2008)
• The Added Value of Concurrently-Administered Temozolomide Versus Adjuvant Temozolomide Alone in Newly-Diagnosed Glioblastoma
  af: Sher, David J., et al.
  Udgivet: (2008)
• ATNT-11 A PHASE I PHARMACODYNAMIC STUDY OF DISULFIRAM AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA AFTER RADIATION THERAPY AND CONCURRENT TEMOZOLOMIDE
  af: Huang, Jiayi, et al.
  Udgivet: (2015)
• Metabolic Tumor Volume Response Assessment Using (11)C-Methionine Positron Emission Tomography Identifies Glioblastoma Tumor Subregions That Predict Progression Better Than Baseline or Anatomic Magnetic Resonance Imaging Alone
  af: Miller, Sean, et al.
  Udgivet: (2019)
• Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma
  af: Mathen, Peter, et al.
  Udgivet: (2020)